Dynavax Technologies | 부채에 대한이자 비용





부채에 대한이자 비용 변화 날짜
AbbVie USD 740M 40M 2025-06
Adma Biologics USD 1.68M 150K 2025-09
Agenus USD 12.8M 7.89M 2025-03
Amgen USD 653M 32M 2025-12
AstraZeneca USD 484M 181M 2025-12
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 2.58M 100K 2025-09
Bristol-Myers Squibb USD 432M 48M 2025-12
Dynavax Technologies USD 1.64M 2K 2025-09
Gilead Sciences USD 256M 2M 2025-09
Glaxosmithkline GBP 177.95M 6.05M 2025-09
Merck USD 412M 85M 2025-12
Minerva Neurosciences USD 2.31M 60K 2024-06
Nektar Therapeutics USD 6.02M 420K 2024-09
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 281M 8M 2025-09
Pfizer USD 711M 59M 2025-12
Regeneron Pharmaceuticals USD 12.2M 7.1M 2025-12
Roche Holding CHF 304M 7.5M 2025-06
Sarepta Therapeutics USD 7.56M 2.33M 2025-09
TG Therapeutics USD 6.72M 4K 2025-09
Vertex Pharmaceuticals USD 3.3M 400K 2025-09


Dynavax Technologies 부채에 대한이자 비용 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Feb 2026.